74 related articles for article (PubMed ID: 3040514)
1. [The menstrual cycle after hormonal growth inhibition in girls].
Kaiser R; Kloppenburg W; Ehmke H; Schwenk H
Geburtshilfe Frauenheilkd; 1987 Jun; 47(6):410-3. PubMed ID: 3040514
[TBL] [Abstract][Full Text] [Related]
2. [Estrogen treatment of excessively tall girls (author's transl)].
Klittich L; Lehr HJ; Schmidt-Elmendorff H; Steyer M
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):831-9. PubMed ID: 212344
[TBL] [Abstract][Full Text] [Related]
3. Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way.
Hennis BC; Boomsma DI; Fijnvandraat K; Gevers Leuven JA; Peters M; Kluft C
Thromb Haemost; 1995 Mar; 73(3):484-7. PubMed ID: 7667832
[TBL] [Abstract][Full Text] [Related]
4. Final height in estrogen-treated patients with Turner syndrome.
Demetriou E; Emans SJ; Crigler JF
Obstet Gynecol; 1984 Oct; 64(4):459-64. PubMed ID: 6091005
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogens and a progestogen on platelet adhesiveness and aggregation in rabbits.
Mitchell HC
J Lab Clin Med; 1974 Jan; 83(1):79-89. PubMed ID: 4357621
[No Abstract] [Full Text] [Related]
6. [Conjugated-estrogen treatment of excessively tall girls (author's transl)].
Stöver B; Kollmann F
Monatsschr Kinderheilkd; 1982 Jan; 130(1):36-40. PubMed ID: 6278298
[TBL] [Abstract][Full Text] [Related]
7. Estrogen treatment of excessively tall girls.
Zachmann M; Ferrandez A; Můrset G; Prader A
Helv Paediatr Acta; 1975 May; 30(1):11-30. PubMed ID: 169220
[TBL] [Abstract][Full Text] [Related]
8. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal treatment of excessive height in girls].
Annee Endocrinol; 1967; 19():103-10. PubMed ID: 5591179
[No Abstract] [Full Text] [Related]
10. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
[TBL] [Abstract][Full Text] [Related]
11. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
Morin A; Guimarey L; Apezteguia M; Santucci Z
Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
[TBL] [Abstract][Full Text] [Related]
12. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
[TBL] [Abstract][Full Text] [Related]
13. [The menstrual cycle in adolescents].
Carol W
Zentralbl Gynakol; 1978; 100(6):360-6. PubMed ID: 566004
[TBL] [Abstract][Full Text] [Related]
14. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
Venturoli S; Porcu E; Gammi L; Fabbri R; Paradisi R; Flamigni C; Patrono D; Capelli M; Paoletti C
Acta Eur Fertil; 1988; 19(3):129-34. PubMed ID: 2976224
[TBL] [Abstract][Full Text] [Related]
15. [Puberty and ovarian function following cytostatic therapy in childhood].
Distler W; Kuhrke H; Jürgens H; Graf M
Geburtshilfe Frauenheilkd; 1986 Apr; 46(4):237-41. PubMed ID: 3086179
[TBL] [Abstract][Full Text] [Related]
16. [Somatic puberty development in girls].
Largo RH; Prader A
Monatsschr Kinderheilkd; 1987 Aug; 135(8):479-84. PubMed ID: 3657814
[TBL] [Abstract][Full Text] [Related]
17. [Causes of menstrual disorders in adolescent girls--a retrospective study].
Bieniasz J; Zak T; Laskowska-Zietek A; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):205-10. PubMed ID: 17020657
[TBL] [Abstract][Full Text] [Related]
18. Ethinyl estradiol treatment for growth limitation in girls with Marfan's syndrome--experience from a single center.
Ucar SK; Paterson WF; Donaldson MD; Young D
Endocr Res; 2009; 34(4):109-20. PubMed ID: 19878071
[TBL] [Abstract][Full Text] [Related]
19. World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. World Health Organization Task Force on Adolescent Reproductive Health.
J Adolesc Health Care; 1986 Jul; 7(4):236-44. PubMed ID: 3721946
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
Korkhov VV; Nikanorova SA
Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
